tiprankstipranks
Trending News
More News >
AIFarm (AIFM)
OTHER OTC:AIFM
US Market

AIFarm (AIFM) Financial Statements

Compare
4 Followers

AIFarm Financial Overview

AIFarm's market cap is currently $2.08K. The company's EPS TTM is $; its P/E ratio is ―; AIFarm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 19Dec 18Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -10.48K
Operating Income$ -487.00K$ -85.30K$ -608.01K
EBITDA$ -59.95K$ -110.58K$ 81.66K
Net Income$ -547.00K$ -109.80K$ 54.14K
Balance Sheet
Cash & Short-Term Investments$ 88.27K$ 97.12K$ 583.95K
Total Assets$ 88.27K$ 97.12K$ 583.95K
Total Debt-$ 0.00$ 0.00
Net Debt$ -88.22K$ -97.12K$ -583.95K
Total Liabilities$ 3.48M$ 3.59M$ 5.71M
Stockholders' Equity$ -1.85M$ -1.95M$ -3.58M
Cash Flow
Free Cash Flow$ -590.90K$ -1.41M$ -615.27K
Operating Cash Flow$ -590.90K$ -1.41M$ -615.27K
Investing Cash Flow$ 0.00$ 0.00$ 1.28M
Financing Cash Flow$ 585.79K$ 704.00K$ -204.34K
Currency in USD

AIFarm Earnings and Revenue History

AIFarm Debt to Assets

AIFarm Cash Flow

AIFarm Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.